A patent review of butyrylcholinesterase inhibitors and reactivators 2010-2017
{{output}}
Introduction: Butyrylcholinesterase (BuChE) has obtained a renewed interest as therapeutic target in Alzheimer's disease (AD), when changes in BuChE activity and expression along disease progression were highlighted as well as co... ...